Posts

Showing posts from January, 2023

Pseudorabies Virus Vaccine Market Expected to Expand at a Steady 2022-2030

  According to the Regional Research Reports, the   Global Pseudorabies Virus Vaccine Market  size was valued at million USD in 2021 and will reach multi-million USD by 2030, at a  CAGR of 4.6%  from 2022 to 2030. A pseudorabies vaccine from which both the thymidine kinase and a glycoprotein gene have been deleted, and the E1 gene of classical swine fever (hog cholera) virus inserted, protects both pseudorabies and classical swine fever in regions where both viruses are enzootic. Global Pseudorabies Virus Vaccine Market Segmentation Regional Research Reports has segmented the global pseudorabies virus vaccine market based on product type and application at a regional and global level. Geographically, the research report has considered the five regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Moreover, the research study focuses on the market analysis of the tier-1 countries, such as the USA, China, Germany, India, th...